Skip to main content
Veterinary Medicines

Vetoryl 5 mg hard capsules for dogs

Authorised
  • Trilostane

Product identification

Medicine name:
Vetoryl 5 mg hard capsules for dogs
Vetoryl 5 mg Kapsułka, twarda
Active substance:
  • Trilostane
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Trilostane
    5.00
    milligram(s)
    /
    1.00
    Capsule
Pharmaceutical form:
  • Capsule, hard
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QH02CA01
Authorisation status:
  • Valid
Authorised in:
  • Poland
Package description:
  • 30 capsules, contained in three PVC-PVdc/aluminium foil blisters with 10 capsules/blister.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Dechra Regulatory B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Genera d.d.
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 3089
Date of authorisation status change:
Reference member state:
  • Ireland
Procedure number:
  • IE/V/0514/005
Concerned member states:
  • Austria
  • Belgium
  • Croatia
  • Czechia
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Luxembourg
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 26/03/2025

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 26/03/2025

Summary of Product Characteristics

English (PDF)
Published on: 26/08/2024
Download
Polish (PDF)
Published on: 26/03/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."